Junhang Luo (Anze Yu)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Escherichia Coli

Regulatory T Cells

Epidermal Growth Factor Receptor

Top Venues

Research (Washington, D.C.)

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Junhang Luo, Jinfei Fu, Zheng Yin, Hui Yan, Xiang Xiao, Dawei Zou, Xiaolong Zhang, Xiongbing Zu, Xian C Li, Wenhao Chen
Continuous Expression of Interferon Regulatory Factor 4 Sustains CD8 + T Cell Immunity against Tumor. Research (Washington, D.C.) 6 (2023)
Junhang Luo, Jinfei Fu, Zheng Yin, Hui Yan, Xiang Xiao, Dawei Zou, Xiaolong Zhang, Xiongbing Zu, Xian C Li, Wenhao Chen
Continuous Expression of Interferon Regulatory Factor 4 Sustains CD8 + T Cell Immunity against Tumor. Research (Washington, D.C.) 6 (2023)
Li Luo, Denghui Wei, Yihui Pan, Qiu-Xia Wang, Jian-Xiong Feng, Bing Yu, Tiebang Kang, Junhang Luo, Jiefeng Yang, Song Gao
MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria-dependent dephosphorylation of EGFR. Cancer communications (London, England) (2023)